Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Memantine

Memantine in Saudi Arabia: not individually verified

Also known as: namenda

Not individually verified

We have not confirmed that Memantine specifically is scheduled in Saudi Arabia, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. A placement for memantine was not established under the narcotics law, and the search that failed is recorded rather than summarised. The schedules attached to the Law of Combating Narcotics and Psychotropic Substances, Royal Decree M/39 of 1426 AH, in the version issued on 4 September 2026, were searched from Schedule I to Schedule IV for memantine and no matching entry was verified. The search record reads «سجل البحث الخاص بـ memantine: فُحصت الجداول من الأول إلى الرابع ولم يُتحقق من قيد مطابق.», the item specific search record for memantine, the schedules from the first to the fourth were examined and no matching entry was verified. What was searched: “memantine”, “1-amino-3,5-dimethyladamantane”, «ميمانتين»; no exact Schedule I to IV entry was recovered, and the phencyclidine entry does not cover the adamantane medicine. That last point is the one worth stating: memantine and PCP are both NMDA receptor antagonists, which is a pharmacological resemblance and not a chemical identity, and a schedule entry is not extended by mechanism of action.

Confirm directly with Saudi Arabia’s national drug authority or your own embassy before you rely on anything.

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.